iguratimod has been researched along with Airway Remodeling in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, Y; Huang, C; Mu, B; Zhao, L; Zhou, R | 1 |
1 other study(ies) available for iguratimod and Airway Remodeling
| Article | Year |
|---|---|
Iguratimod ameliorates bleomycin-induced alveolar inflammation and pulmonary fibrosis in mice by suppressing expression of matrix metalloproteinase-9.
Topics: Airway Remodeling; Animals; Anti-Inflammatory Agents; Bleomycin; Chromones; Collagen; Cytokines; Disease Models, Animal; Inflammation Mediators; Male; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice, Inbred C57BL; Pneumonia; Pulmonary Alveoli; Pulmonary Fibrosis; Sulfonamides | 2019 |